![Terry Evans](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 204 329 $ al 31/07/2026
Terry Evans currently works at Fennec Pharmaceuticals, Inc., as Chief Commercial Officer from 2024.
Mr. Evans also formerly worked at Unite Pharma Trade Advisors, as Chief Executive Officer and Currax Pharmaceuticals LLC, as Chief Operating Officer.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 03/08/2026 | 21.351 ( 0,06 % ) | 204 329 $ | 31/07/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| FENNEC PHARMACEUTICALS INC. | Corporate Officer/Principal | 28/10/2024 |
| Empresas | Cargo | Fin |
|---|---|---|
Currax Pharmaceuticals LLC
 Currax Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops medicines | Director de Operaciones | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 2 |
|---|---|
Fennec Pharmaceuticals, Inc.
 Fennec Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops and commercializes therapeutic products which dedicated to improving the lives of children with cancer who experience hearing loss | Health Technology |
Currax Pharmaceuticals LLC
Currax Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops medicines | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
